New BRCA-targeting drug could offer hope in treating advanced prostate cancer
Talazoparib, a new precision drug, can keep cancer in check in some men with advanced prostate cancer who have run
Read more
Talazoparib, a new precision drug, can keep cancer in check in some men with advanced prostate cancer who have run
Read moreNIH director on disagreements over face masks, surging Delta cases National Institutes of Health Director Dr. Francis Collins calls a
Read moreResearchers from Hackensack Meridian University Medical Center and Berry Consultants, LLC, Austin, Texas have developed a new model to help
Read moreResearchers from The Australian National University (ANU), in collaboration with The Florey Institute of Neuroscience and Mental Health, have developed
Read moreIncreasing knowledge about genomic biomarkers has facilitated better monitoring and personalized management of patients with B-cell malignant tumors. A new
Read moreA new tool gauges the degree of chronic inflammation in a person’s body to determine their “immunological age;” this number
Read moreFrontotemporal dementia is the second most common cause of dementia in the working age population. Its diagnostics are complicated by
Read moreResearchers from 12 Spanish hospitals took part with the aim of uncovering clinical and prognostic characteristics in solid organ recipients
Read moreIn a new study published today in the American Journal of Human Genetics, researchers announced the development of a new
Read moreDrugs that are being trialed to treat leukemia could also be used to fight bowel cancer after a breakthrough by
Read more